ENLIE Pharmaceutical JSC (HSTC:BCP) Forward Dividend Yield %: 0.00% (As of Jun. 27, 2026)


HSTC:BCP ENLIE Pharmaceutical JSC HSTC:BCP
25 GF Score
Price ₫10,600.00
View Full Analysis

What is ENLIE Pharmaceutical JSC Forward Dividend Yield %?

ENLIE Pharmaceutical JSC HSTC:BCP 25 Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus rates HSTC:BCP with a GF Score™ of 25/100. Among 504 Drug Manufacturers companies, ENLIE Pharmaceutical JSC ranks worse than 198412.5% on this metric.

As of today (2026-06-27), the Forward Annual Dividend Yield of ENLIE Pharmaceutical JSC is 0.00%.

As of today (2026-06-27), the Trailing Annual Dividend Yield of ENLIE Pharmaceutical JSC is 0.00%.

HSTC:BCP's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.08
* Ranked among companies with meaningful Forward Dividend Yield % only.

ENLIE Pharmaceutical JSC's Dividends per Share for the six months ended in . 20 was ₫0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

ENLIE Pharmaceutical JSC  (HSTC:BCP) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

ENLIE Pharmaceutical JSC Forward Dividend Yield % Related Terms

HSTC:BCP vs : Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENLIE Pharmaceutical JSC Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ENLIE Pharmaceutical JSC's Forward Dividend Yield % falls into.


HSTC:BCP
25GF Score
ENLIE Pharmaceutical JSC HSTC:BCP
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENLIE Pharmaceutical JSC Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a Forward Dividend Yield % of 0.00% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ENLIE Pharmaceutical JSC and its competitors. According to the industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 504 companies in the Drug Manufacturers industry.
Is ENLIE Pharmaceutical JSC's Forward Dividend Yield % too high?
ENLIE Pharmaceutical JSC's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 504 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's Forward Dividend Yield % compare to ?
According to the Drug Manufacturers industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 504 companies for Forward Dividend Yield %. This places ENLIE Pharmaceutical JSC in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ENLIE Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ENLIE Pharmaceutical JSC's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENLIE Pharmaceutical JSC Business Description

Comparable Companies
Address NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score

Get the complete analysis for HSTC:BCP

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫10,600.00
Price